Skip Navigation
Skip to contents
ABOUT
Aims and scope
Editorial board
Best practice
Open access
Journal catalog
Contact us
BROWSE ARTICLES
New issue
All issues
Accepted articles
COVID-19 in epiH
Article category
Most read articles
Most download articles
Most cited articles
Author index
Metrics
PUBLICATION ETHICS
Research and publication ethics
FOR CONTRIBUTORS
Instructions to authors
Author checklist
Copyright transfer agreement
Article-processing charge
KSE
Contact us
E-SUBMISSION
SEARCH
Search
Advanced Search
mobile menu button
ABOUT
Aims and scope
Editorial board
Best practice
Open access
Journal catalog
Contact us
BROWSE ARTICLES
New issue
All issues
Accepted articles
COVID-19 in epiH
Article category
Most read articles
Most download articles
Most cited articles
Author index
Metrics
PUBLICATION ETHICS
Research and publication ethics
FOR CONTRIBUTORS
Instructions to authors
Author checklist
Copyright transfer agreement
Article-processing charge
Articles
Page Path
HOME >
Epidemiol Health
>
Volume 47; 2025
> Article
Correspondence
Letter to the Editor: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study
Zhanyi Zhou
Epidemiol Health 2025;47e2025053-0
DOI:
https://doi.org/10.4178/epih.e2025053
Published online: September 20, 2025
Author Affiliations
Article notes
Zhejiang Chinese Medical University, Hangzhou, China
Corresponding author: Zhanyi Zhou,
Email:
201812210101030@zcmu.edu.cn
Received: 12 August 2025 • Accepted: 22 August 2025
prev
next
205
Views
16
Download
0
Crossref
0
Scopus
Full Article
Full Article
Figure & data
Reference
Citations
Metrics
Download PDF
Facebook
Twitter
Linked
Naver
Figure & Data
References
Citations
Citations to this article as recorded by
Cite
Related articles
Authors’ Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study
Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study
TOP